Anti-PD-1 in Combination With Chemotherapy as First-Line Treatment to Lung Cancer | 百济神州

⟵ Back to Search Results

Anti-PD-1 in Combination With Chemotherapy as First-Line Treatment to Lung Cancer

Beigene Study ID

BGB-A317-206

ClinicalTrials.gov ID

NCT03432598

Clinical Drug Trials ID

CTR20170361

Study Overview

Sex: All

Age: 18 Years to 75 Years Adult, Older Adult)

Accepts Healthy Volunteers? yes

No Study Documents

Study Overview

Sex: All

Age: 18 Years to 75 Years Adult, Older Adult)

Accepts Healthy Volunteers? yes

No Study Documents